[Federal Register Volume 63, Number 96 (Tuesday, May 19, 1998)]
[Notices]
[Page 27587]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-13323]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances, Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that in a letter dated February 5, 
1998, High Standard Products, 1100 W. Florence Avenue, #, 
Inglewood, California 90301, made application to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of 
normorphine (9313), a basic class of controlled substance in Schedule 
I.
    The firm plans to manufacture an analytical reference standard.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than July 20, 1998.


    Dated: May 6, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 98-13323 Filed 5-18-98; 8:45 am]
BILLING CODE 4410-09-M